Nordea Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Buy
22,047
+4,260
+24% +$2.39M 0.01% 432
2026
Q1
$9.84M Buy
17,787
+1,190
+7% +$763K 0.01% 449
2025
Q4
$11.3M Buy
16,597
+8,845
+114% +$6.02M 0.01% 422
2025
Q3
$4.9M Sell
7,752
-305
-4% -$185K ﹤0.01% 597
2025
Q2
$4.3M Buy
8,057
+361
+5% +$173K ﹤0.01% 586
2025
Q1
$3.19M Buy
7,696
+1,287
+20% +$559K ﹤0.01% 620
2024
Q4
$2.66M Buy
6,409
+334
+5% +$147K ﹤0.01% 638
2024
Q3
$3.06M Sell
6,075
-7,881
-56% -$3.83M ﹤0.01% 617
2024
Q2
$6.86M Buy
13,956
+237
+2% +$119K 0.01% 470
2024
Q1
$7.45M Buy
13,719
+1,839
+15% +$1M 0.01% 476
2023
Q4
$6.6M Buy
11,880
+9
+0.1% +$4.22K 0.01% 482
2023
Q3
$5.22M Sell
11,871
-448
-4% -$223K 0.01% 494
2023
Q2
$6.19M Sell
12,319
-247
-2% -$118K 0.01% 471
2023
Q1
$6.25M Buy
12,566
+283
+2% +$135K 0.01% 477
2022
Q4
$4.96M Sell
12,283
-11,208
-48% -$4.35M 0.01% 522
2022
Q3
$7.87M Sell
23,491
-8,880
-27% -$3.26M 0.01% 414
2022
Q2
$11.3M Sell
32,371
-8,722
-21% -$3.56M 0.02% 359
2022
Q1
$22.7M Sell
41,093
-2,316
-5% -$1.22M 0.03% 308
2021
Q4
$28.8M Sell
43,409
-1,106
-2% -$694K 0.03% 294
2021
Q3
$28.3M Sell
44,515
-1,468
-3% -$986K 0.04% 303
2021
Q2
$29M Sell
45,983
-7,069
-13% -$3.9M 0.04% 297
2021
Q1
$26M Buy
53,052
+1,539
+3% +$771K 0.04% 297
2020
Q4
$25.8M Buy
51,513
+5,630
+12% +$2.52M 0.04% 281
2020
Q3
$17.7M Buy
45,883
+36,911
+411% +$13.6M 0.03% 284
2020
Q2
$2.92M Buy
8,972
+4,782
+114% +$1.38M ﹤0.01% 672
2020
Q1
$1.01M Buy
4,190
+144
+4% +$37.6K ﹤0.01% 716
2019
Q4
$1.06M Hold
4,046
﹤0.01% 744
2019
Q3
$1.11M Sell
4,046
-173
-4% -$48.1K ﹤0.01% 746
2019
Q2
$1.16M Sell
4,219
-266
-6% -$65.5K ﹤0.01% 746
2019
Q1
$1M Buy
4,485
+40
+0.9% +$8.26K ﹤0.01% 980
2018
Q4
$827K Hold
4,445
﹤0.01% 987
2018
Q3
$1.11M Hold
4,445
﹤0.01% 988
2018
Q2
$969K Hold
4,445
﹤0.01% 845
2018
Q1
$851K Sell
4,445
-156
-3% -$28.8K ﹤0.01% 881
2017
Q4
$720K Hold
4,601
﹤0.01% 842
2017
Q3
$715K Buy
4,601
+124
+3% +$19.6K ﹤0.01% 819
2017
Q2
$723K Hold
4,477
﹤0.01% 812
2017
Q1
$692K Buy
4,477
+2,585
+137% +$356K ﹤0.01% 810
2016
Q4
$222K Hold
1,892
﹤0.01% 929
2016
Q3
$213K Hold
1,892
﹤0.01% 918
2016
Q2
$176K Buy
+1,892
New +$162K ﹤0.01% 898

Other funds holding IDXX

Nordea Investment Management's IDXX Position: Q2 2026 in Review

Nordea Investment Management increased its Idexx Laboratories (IDXX) stake by 24% in Q2 2026, buying an estimated $2.39M and bringing the position to 22,047 shares worth $11.6M. The position accounts for 0.01% of the portfolio, ranked #432.

Nordea Investment Management first reported a position in IDXX in Q2 2016 and has held it in 41 quarters since. The position peaked at $29M in Q2 2021. 659 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Nordea Investment Management held 22,047 shares of Idexx Laboratories worth $11.6M as of Q2 2026.
  • Nordea Investment Management bought 4,260 Idexx Laboratories shares in Q2 2026, an estimated $2.39M.
  • Idexx Laboratories made up 0.01% of Nordea Investment Management's portfolio in Q2 2026, its #432 holding.
  • Nordea Investment Management first reported a position in Idexx Laboratories in Q2 2016 and has held it in 41 quarters since.
  • Nordea Investment Management's Idexx Laboratories position peaked at $29M in Q2 2021.
  • 659 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.